Luxdegalutamide

Luxdegalutamide · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Luxdegalutamide, covering 2026-04-16 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer [Phase 1]